Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 27, 2026AIDS Research and TherapyOpen Access

Prevalence and determinants of anemia among people living with HIV receiving antiretroviral therapy in public health facilities in Jigjiga, Ethiopia

View Full Paper
Ask AI
Bookmark
Share

Authors

JIJamaal IbrahimSASahardiid AbdilahiMOMohamed Osman

Discussion

Loading...

Member takes

Overview

Cross-sectional study assesses anemia prevalence in HIV patients receiving antiretroviral therapy, indicating critical health needs.

Key Points

  • This study aimed to assess anemia prevalence and identify associated factors in HIV patients on antiretroviral therapy.
  • Cross-sectional study conducted from July 11 to August 12, 2023.
  • Involved 392 HIV patients receiving antiretroviral therapy in Jigjiga, Ethiopia.
  • Data collection used structured questionnaires and hemoglobin measurements; analysis performed using SPSS with multivariate logistic regression.
  • Overall prevalence of anemia was 39% (95% CI: 34.3–44.2).
  • Among those with anemia: 0.6% had severe anemia, 33.5% had moderate anemia, and 4.9% had mild anemia.
  • Significant associations found with anemia linked to female sex, opportunistic infections, and low dietary diversity (p < 0.05).

Cite This Study

Ibrahim et al. (2026) studied this question.

synapsesocial.com/papers/6a3f6817aea7db3c1953f4a6https://doi.org/10.1186/s12981-026-00912-2
View Full Paper
Ask AI
Bookmark
Share